Collegium Pharmaceutical Correlations
COLL Stock | USD 32.17 0.13 0.41% |
The current 90-days correlation between Collegium Pharmaceutical and Eagle Pharmaceuticals is 0.15 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Collegium Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Collegium Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Collegium Pharmaceutical Correlation With Market
Modest diversification
The correlation between Collegium Pharmaceutical and DJI is 0.25 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Collegium Pharmaceutical and DJI in the same portfolio, assuming nothing else is changed.
Collegium | Build AI portfolio with Collegium Stock |
Moving together with Collegium Stock
0.73 | 603139 | Shaanxi Kanghui Pharm | PairCorr |
0.64 | 002332 | Zhejiang Xianju Phar | PairCorr |
0.9 | VTRS | Viatris | PairCorr |
0.77 | TSND | TerrAscend Corp | PairCorr |
Moving against Collegium Stock
0.68 | HIKAL | Hikal Limited | PairCorr |
0.67 | HCM | HUTCHMED China | PairCorr |
0.59 | CRDL | Cardiol Therapeutics | PairCorr |
0.48 | DRRX | Durect | PairCorr |
0.35 | VM | Voyageur Pharmaceuticals | PairCorr |
0.79 | AUROPHARMA | Aurobindo Pharma | PairCorr |
0.46 | VTYX | Ventyx Biosciences | PairCorr |
0.33 | SYNCOMF | Syncom Formulations | PairCorr |
0.31 | EOLS | Evolus Inc | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Collegium Stock performing well and Collegium Pharmaceutical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Collegium Pharmaceutical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
EGRX | 3.09 | (1.07) | 0.00 | (0.47) | 0.00 | 5.94 | 62.87 | |||
ANIP | 1.56 | 0.40 | 0.30 | 0.50 | 1.04 | 4.08 | 20.88 | |||
PAHC | 2.19 | 0.34 | 0.18 | 0.26 | 1.78 | 4.46 | 23.83 | |||
PBH | 1.22 | (0.39) | 0.00 | (0.23) | 0.00 | 1.71 | 11.56 | |||
AMPH | 2.10 | 0.07 | 0.05 | 0.09 | 2.29 | 6.00 | 20.28 | |||
SNDX | 2.78 | 0.76 | 0.26 | 1.16 | 2.12 | 6.86 | 26.45 | |||
ENTA | 5.19 | 1.09 | 0.19 | 0.51 | 5.12 | 8.93 | 112.94 | |||
IRWD | 5.18 | 1.06 | 0.21 | 0.47 | 4.67 | 11.54 | 27.96 |
Collegium Pharmaceutical Corporate Management
Shirley JD | General VP | Profile | |
Bart Dunn | Executive Development | Profile | |
Scott Sudduth | Head Operations | Profile | |
Christopher MD | Vice Relations | Profile | |
Marlo Manning | Head HR | Profile |